Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood

Bibliographic Details
Title: Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood
Authors: Nina A. Mikirova, Santosh Kesari, Thomas E. Ichim, Neil H. Riordan
Source: Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-8 (2017)
Publisher Information: BMC, 2017.
Publication Year: 2017
Collection: LCC:Medicine
Subject Terms: Medicine
More Details: Abstract Background Chronic inflammation is a predisposing factor to numerous degenerative diseases including cancer, heart failure and Alzheimer’s disease. Infla-Kine is a natural supplement comprised of a proprietary blend of Lactobacillus fermentum extract, burdock seed (arctigenin), zinc, alpha lipoic acid, papaya enzyme and an enhanced absorption bio-curcumin complex (BCM-95®). Methods Infla-Kine was administered twice daily to 24 health volunteers for 4 weeks. Quantitative RT-PCR was used to assess mRNA transcripts of IL-1b, IL8, IL-6, NF-κB, and TNF-α from peripheral blood mononuclear cells (PBMC). C reactive protein (CRP) was measured from serum. Additionally, quality of life questionnaires were employed to assess general feeling of well-being. Assessments were made before treatment and at conclusion of treatment (4 weeks). Results As compared to pre-treatment, after 4 weeks, a statistically significant reduction of IL8, IL-6, NF-κB, and TNF-α transcripts was observed in PBMC. Furthermore, reduction of IL-1b transcript and serum CRP was observed but did not reach statistical significance. Quality of life improvements were most prevalent in muscle and joint pains. Conclusions Overall, our data demonstrate that twice daily administration of Infla-Kine for 4 weeks reduces inflammatory markers and quality of life in healthy volunteers.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1479-5876
Relation: http://link.springer.com/article/10.1186/s12967-017-1315-4; https://doaj.org/toc/1479-5876
DOI: 10.1186/s12967-017-1315-4
Access URL: https://doaj.org/article/7c48e68805b44789b574c4ea14046990
Accession Number: edsdoj.7c48e68805b44789b574c4ea14046990
Database: Directory of Open Access Journals
More Details
ISSN:14795876
DOI:10.1186/s12967-017-1315-4
Published in:Journal of Translational Medicine
Language:English